Braxia Scientific Corp. — Form D/A

Braxia Scientific Corp. of VANCOUVER, A1, a company, filed a Form D amendment with the SEC on 2024-03-21. The offering totals $730K, of which $249K was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (26)

Showing 25 of 26 people.

NameRoleLocation
Olga CwiekDirectorToronto, A6
Jerry HabudaDirectorToronto, A6
Roger McIntyreDirectorToronto, A6
Stephen BrooksExecutive OfficerToronto, A6
Daniel HerreraExecutive OfficerToronto, A6
Kevin KratiukExecutive OfficerToronto, A6
Roger McIntyreExecutive OfficerToronto, A6
Peter RizakosExecutive OfficerToronto, A6
Joshua RosenblatExecutive OfficerToronto, A6
Jason WolkoveExecutive OfficerToronto, A6
David GreenbergDirectorChicago, IL
Stephen BrohmanExecutive OfficerVancouver, A1
Kevin S KratiukExecutive OfficerToronto, A6
Jerry S HabudaDirectorToronto, A6
Jason S WolkoveExecutive OfficerToronto, A6
Peter S RizakosExecutive OfficerToronto, A6
Roger S McIntyreDirectorToronto, A6
Roger S McIntyreExecutive OfficerToronto, A6
Stephen S BrooksExecutive OfficerToronto, A6
Olga S CwiekDirectorToronto, A6
Joshua S RosenblatExecutive OfficerToronto, A6
MATTHEW FISHDirectorVANCOUVER, A1
MATTHEW FISHExecutive OfficerVANCOUVER, A1
Pat McCutcheonDirectorVANCOUVER, A1
Gareth BirdsallDirectorVANCOUVER, A1

Other filings by this issuer (5)

FiledFormOfferingSold
2023-08-23D/A$2.3M$2.3M
2023-03-24D$730K$249K
2022-08-22D$2.3M$2.3M
2022-02-14D$5.3M$2.4M
2020-06-23D$1.6M$951K

More